PAX5 and acute lymphoblastic leukemia: One Ph‐like B‐ALL subtype is characterized by the PAX5‐JAK2 rearrangement (Nebral et al, 2009; Roberts et al, 2012), which we have studied here with regard to its molecular and oncogenic function in a mouse model.